The biomarkers imaging kit maker will use proceeds from the Applied Materials-backed series C round to fund international expansion plans.
US-based biological detection system developer Ultivue today raised $22m in a series C round that included Applied Ventures, the corporate venturing unit of semiconductor equipment manufacturer Applied Materials.
Venture capital firm Northpond Ventures led the round, investing alongside 6 Dimensions Capital, the investment vehicle formed by medical research firm WuXi PharmaTech’s corporate venturing arm, WuXi Healthcare Ventures, as well as Yonghua Capital and Arch Venture Partners.
Ultivue is creating an imaging kit that is designed to help locate biomarkers, naturally occurring molecule,…
